Menü
Microsoft selbst warnt vor der Verwendung von Internet Explorer, da er nicht mehr den neuesten Web- und Sicherheitsstandards entspricht. Wir können daher nicht garantieren, dass die Seite im Internet Explorer in vollem Umfang funktioniert. Nutze bitte Chrome oder Firefox.

Blog

4 Hotel REITs to Watch for Potential Upside This Earnings SeasonPhoto, wide shot, wide-angle lens,  Retail store, Midday, harsh overhead sunlight, directional sunlightt, photo by Thomas Heaton: https://img.midjourneyapi.xyz/temp/bda07ced-e79e-4489-b731-ada601660c8e.png
4 Hotel REITs to Watch for Potential Upside This Earnings Season

With the first-quarter earnings season underway, early reports are grabbing investors' attention for reporting solid profits. Rather than chasing stocks that have already surged on solid reports

TTE Q1 Earnings and Sales Beat Estimates on Strong Realized Prices
TTE Q1 Earnings and Sales Beat Estimates on Strong Realized Prices

TotalEnergies SE TTE reported first-quarter 2026 operating earnings of $2.45 (€2.10) per share, which surpassed the Zacks Consensus Estimate of $1.99 by 23.1%. The bottom line improved 34% from the

ARIS to Report Q1 Earnings: What's in Store for the Stock?Photo, wide shot, wide-angle lens,  Gold mine, Midday, harsh overhead sunlight, directional sunlightt, photo by Thomas Heaton: https://img.midjourneyapi.xyz/temp/94faf2bd-99c1-4ea6-b55d-fdcab23c3865.png
ARIS to Report Q1 Earnings: What's in Store for the Stock?

Aris Mining Corporation ARIS is set to release its first-quarter 2026 results on May 6, after market close.

Over the past 60 days, the Zacks Consensus Estimate for Aris Mining’s first-quarter

2 Silver Mining Stocks to Watch Amid Industry ChallengesPhoto, wide shot, wide-angle lens,  Gold mine, Midday, harsh overhead sunlight, directional sunlightt, photo by Thomas Heaton: https://img.midjourneyapi.xyz/temp/94faf2bd-99c1-4ea6-b55d-fdcab23c3865.png
2 Silver Mining Stocks to Watch Amid Industry Challenges
After a massive 170% rally in 2025, silver prices have lost momentum, rising just 2.7% year to date. The slowdown reflects growing expectations that central banks will keep interest rates higher for
Capitalizing on the AI Buildout: High-Conviction Stock PicksPhoto, wide shot, wide-angle lens,  Networking equipment supplier, sunset photo at golden hour, photo by Marc Adamus: https://img.midjourneyapi.xyz/temp/66e3509e-f4c6-4a7b-8e88-53fcc02cf17f.png
Capitalizing on the AI Buildout: High-Conviction Stock Picks

An updated edition of the March 11, 2026, article.Artificial Intelligence (AI) allows machines to analyze large volumes of data, identify patterns, and make independent decisions. It is transforming

Apple's Q2 Earnings: Strong iPhone 17 Shipment to Aid Top-Line Growth
Apple's Q2 Earnings: Strong iPhone 17 Shipment to Aid Top-Line Growth

Apple’s AAPL second-quarter fiscal 2026 results, to be reported on April 30, are expected to benefit from strong iPhone 17 sales. The device accounted for 59.3% of net sales in the first quarter of

Amphenol's Q1 Earnings Beat Estimates, Revenues Up Y/Y, Shares Rise
Amphenol's Q1 Earnings Beat Estimates, Revenues Up Y/Y, Shares Rise

Amphenol APH delivered record first-quarter 2026 results, with adjusted earnings of $1.06 per share, up 68.3% from the year-ago quarter and beating the Zacks Consensus Estimate by 11.6%. Revenues

Here's How to Play Berkshire Hathaway Stock Before Q1 Earnings
Here's How to Play Berkshire Hathaway Stock Before Q1 Earnings

Berkshire Hathaway BRK.B is expected to witness an improvement in its top and bottom lines when it reports first-quarter 2026 results. 

The Zacks Consensus Estimate for BRK.B’s first-quarter

Navient Q1 Earnings Beat as Expenses & Provisions Fall Y/Y, Stock Down
Navient Q1 Earnings Beat as Expenses & Provisions Fall Y/Y, Stock Down

Navient Corporation NAVI reported first-quarter 2026 earnings per share (EPS) of 20 cents, surpassing the Zacks Consensus Estimate of 17 cents. It reported earnings of 28 cents in the prior-year

OPKO Health Q1 Earnings In-Line on Product Gains, Revenues Down Y/Y
OPKO Health Q1 Earnings In-Line on Product Gains, Revenues Down Y/Y

OPKO Health, Inc. OPK posted a first-quarter 2026 loss of 7 cents per share, in line with the Zacks Consensus Estimate. The bottom line improved from a loss of 10 cents in the year-ago quarter.

Fair Isaac Q2 Earnings Beat Estimates on Scores, Revenue Up Y/Y
Fair Isaac Q2 Earnings Beat Estimates on Scores, Revenue Up Y/Y

Fair Isaac FICO posted a strong second-quarter fiscal 2026, with non-GAAP earnings of $12.5 per share, beating the Zacks Consensus Estimate by 13.33% and rising 60.1% from the year-ago quarter

CoStar Group Q1 Earnings Beat Estimates, Revenues Up Y/Y, Shares Fall
CoStar Group Q1 Earnings Beat Estimates, Revenues Up Y/Y, Shares Fall

CoStar Group CSGP reported non-GAAP earnings of 23 cents per share in the first quarter of 2026, which surpassed the Zacks Consensus Estimate by 30.16%. The company reported earnings of 15 cents per

Innodata vs. ExlService: Which AI Data Stock Is the Better Buy?Photo, wide shot, wide-angle lens,  Telecom equipment supplier, Midday, harsh overhead sunlight, directional sunlightt, photo by Thomas Heaton: https://img.theapi.app/temp/3967c11c-b755-4d39-87d0-acc853384c80.png
Innodata vs. ExlService: Which AI Data Stock Is the Better Buy?

The data and artificial intelligence services space is evolving rapidly as enterprises scale generative AI, automation and analytics across operations. Within this landscape, Innodata Inc. INOD and

Teradyne Q1 Earnings Beat Estimates, Revenues Increase Y/Y, Share Down
Teradyne Q1 Earnings Beat Estimates, Revenues Increase Y/Y, Share Down

Teradyne TER delivered first-quarter 2026 non-GAAP earnings of $2.56 per share, up 241.3% year over year and beating the Zacks Consensus Estimate by 21.43%. Revenue climbed 86.9% from the year-ago

UBS Group Q1 Earnings & Revenues Rise Y/Y Despite Higher Expenses
UBS Group Q1 Earnings & Revenues Rise Y/Y Despite Higher Expenses

UBS Group AG UBS reported a first-quarter 2026 net profit attributable to shareholders of $3.04 billion compared with $1.69 billion in the prior-year quarter.

Results were driven by the strong

Is Amneal (AMRX) a Solid Growth Stock? 3 Reasons to Think "Yes"
Is Amneal (AMRX) a Solid Growth Stock? 3 Reasons to Think "Yes"

Growth stocks are attractive to many investors, as above-average financial growth helps these stocks easily grab the market's attention and produce exceptional returns. However, it isn't easy to

Rockwell Automation (ROK) is an Incredible Growth Stock: 3 Reasons Why
Rockwell Automation (ROK) is an Incredible Growth Stock: 3 Reasons Why

Growth investors focus on stocks that are seeing above-average financial growth, as this feature helps these securities garner the market's attention and deliver solid returns. But finding a great

Looking for a Growth Stock? 3 Reasons Why Churchill Downs (CHDN) is a Solid Choice
Looking for a Growth Stock? 3 Reasons Why Churchill Downs (CHDN) is a Solid Choice

Growth investors focus on stocks that are seeing above-average financial growth, as this feature helps these securities garner the market's attention and deliver solid returns. But finding a great

EPD vs AROC: Which Midstream Player Is the Better Investment Now?
EPD vs AROC: Which Midstream Player Is the Better Investment Now?

Enterprise Products Partners LP EPD and Archrock Inc. AROC are two major players in the midstream energy space with slightly different business operations. EPD operates an integrated midstream asset

Humana Beats Q1 Earnings Estimates on Increasing Premiums
Humana Beats Q1 Earnings Estimates on Increasing Premiums

Humana Inc. HUM reported first-quarter 2026 adjusted earnings of $10.31 per share, which beat the Zacks Consensus Estimate by 3.5%. However, the bottom line fell 11% year over year.

Revenues

RNR Q1 Earnings Beat on Lower Expenses & Strong Investment Results
RNR Q1 Earnings Beat on Lower Expenses & Strong Investment Results

RenaissanceRe Holdings Ltd. RNR reported first-quarter 2026 operating income of $13.75 per share, which surpassed the Zacks Consensus Estimate by 24.2%.  The bottom line improved from the year-ago

Regeneron Q1 Earnings Top, Sales Up on Dupixent & Eylea HD StrengthPhoto, wide shot, wide-angle lens,  Pharmaceutical company, Midday, harsh overhead sunlight, directional sunlightt, photo by Art Wolfe: https://img.midjourneyapi.xyz/temp/7ae4a134-dd01-4c80-a621-18399f5a2541.png
Regeneron Q1 Earnings Top, Sales Up on Dupixent & Eylea HD Strength

Regeneron Pharmaceuticals, Inc. REGN reported first-quarter 2026 adjusted earnings per share (EPS) of $9.47, which comfortably beat the Zacks Consensus Estimate of $8.52 and was up from $8.22

Utah Medical's Q1 Earnings Fall Y/Y Due to Elevated Litigation CostsPhoto, wide shot, wide-angle lens,  Clinical research organization, sunset photo at golden hour, photo by Peter Lik: https://img.midjourneyapi.xyz/temp/02f7778c-d723-4fb3-bdef-fabb7e5fc9c8.png
Utah Medical's Q1 Earnings Fall Y/Y Due to Elevated Litigation Costs

Shares of Utah Medical Products, Inc. UTMD have declined 4.3% since the company reported its earnings for the quarter ended March 31, 2026, underperforming the S&P 500 index, which rose 0.6% over

Veralto Q1 Earnings & Revenues Beat Estimates, Increase Y/Y
Veralto Q1 Earnings & Revenues Beat Estimates, Increase Y/Y

Veralto VLTO reported impressive first-quarter 2026 results, with both earnings and revenues beating the Zacks Consensus Estimate.

VLTO’s adjusted earnings per share (EPS) of $1.07 beat the

GEHC Q1 Earnings Miss Estimates, Revenues Beat, Net Margin DeclinesPhoto, wide shot, wide-angle lens,  Medical device manufacturer, Blue hour, twilight, cool, ISO1200, slow shutter speed, photo by Michael Light: https://img.theapi.app/temp/3a7f6312-1eee-4702-9005-93cc1e62f970.png
GEHC Q1 Earnings Miss Estimates, Revenues Beat, Net Margin Declines

GE HealthCare Technologies Inc. GEHC reported first-quarter 2026 adjusted earnings per share (EPS) of 99 cents, which missed the Zacks Consensus Estimate of $1.07 by 7.5%. Also, the bottom line